News on issues related to managing clinical laboratories.
How labs — including those that are part of other healthcare systems — offering PGx testing will react to Inova's decision to not engage with the FDA remains to be seen.
A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.
The American Academy of Family Physicians said that the changes being considered by CMS would increase the financial burden on laboratories.
Pharmacogenetics and legal experts took particular issue with the agency's suggestion that "established" drug/gene relationships are found only in FDA-approved drug labels.
The spread of POC testing technology along with changes in state regulations and pharmacist education are driving an increase in pharmacist-administered testing.
